Diabetes is life long affliction that causes a person’s blood sugar level to become too high. With the two main types of diabetes, type 2 is far more common. Around 90% of all adults with diabetes have type 2.
Types
Type 2 is where the body is not creating enough insulin or the body is not reacting correctly to the insulin. This type usually requires the managing of medication, finding the right medication for each person can take time. Also many of the medications have side affects.
Type 1 is when the level of glucose in blood to be too high. This happens when the body isn’t producing enough of the hormone insulin which controls the levels of glucose in blood.
Both types are manageable with the correct advice and medication.
There are articles below that explore the condition in many different ways. Covering new research and evidence.
Afon Technology, founded by Dr Sabih Chaudhry in 2019, has been a leader in diabetes innovation with its Glucowear™ device, the world’s first non-invasive glucose sensor that continuously monitors blood sugar levels in real-time.
New research announced today at the Diabetes UK Professional Conference has revealed shocking health inequalities between people with Type 1 diabetes depending on where they live.
John Grumitt, CEO of Changing Health and Chair of IDEAL Group highlights the importance of tackling the biggest challenges in diabetes care – together.
Professor Graham MacGregor, Chair of Action on Sugar, discusses stopping excessive sugar consumption, whilst investigating obesity and type 2 diabetes.
Adrian Sanders, Secretary-General of The Parliamentarians for Diabetes Global Network (PDGN) reveals how organising globally, acting locally is a sound approach when it comes to tackling diabetes.
Barbara Harpham, Chair of the UK-based Medical Technology Group, explains the role that technology can play in reducing the financial and societal burden of diabetes.
James Cotterell, Director at BBI Healthcare, argues that prescribing products that treat low blood sugar with a precise and measured dose of glucose can improve patient outcomes, reduce patient anxiety and save the NHS money
A new study supported by the World Health Organisation found that higher dietary fibre intake is associated with a reduced risk of several chronic diseases.
PHE launches new Change4Life campaign to help families cut back on sugar after research reveals children have already exceeded the maximum sugar intake for an 18-year-old by the age of 10.
Professor Iain Chapple from the University of Birmingham UK, explains the link between periodontitis and non-communicable diseases such as Type 2 diabetes
Professor John Wilding from the University of Liverpool discusses how more effective use of treatments and greater support for healthcare professionals can make the difference in the battle against Type 2 diabetes
Chanelle Corena, Type 2 Prevention Lead at Diabetes UK, highlights the 12.3 million people in the UK who are at an increased risk of developing Type 2 diabetes and precisely why prevention and a change in behaviour is crucial in this vein
